Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 7
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Deep learning-based white matter lesion volume on CT is associated with outcome after acute ischemic stroke.
van Voorst H, Pitkänen J, van Poppel L, de Vries L, Mojtahedi M, Martou L, Emmer BJ, Roos YBWEM, van Oostenbrugge R, Postma AA, Marquering HA, Majoie CBLM, Curtze S, Melkas S, Bentley P, Caan MWA; MR CLEAN No-IV and CONTRAST consortium collaborators. van Voorst H, et al. Eur Radiol. 2024 Jan 29. doi: 10.1007/s00330-024-10584-z. Online ahead of print. Eur Radiol. 2024. PMID: 38285103
Sex differences in outcomes after endovascular treatment in posterior circulation stroke: results from the MR CLEAN Registry.
Ali M, Dekker L, Ali M, Van Zwet EW, Hofmeijer J, Nederkoorn PJ, Majoie CB, van Es AC, Uyttenboogaart M, van der Meij A, van Walderveen MAA, Visser MC, Dippel DW, Schonewille WJ, van den Wijngaard IR, Kruyt ND, Wermer MJH; MR CLEAN Registry Investigators. Ali M, et al. J Neurointerv Surg. 2024 Jan 3:jnis-2023-021086. doi: 10.1136/jnis-2023-021086. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38171605
Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation.
van Voorst H, Hoving JW, Koopman MS, Daems JD, Peerlings D, Buskens E, Lingsma H, Marquering HA, de Jong HWAM, Berkhemer OA, van Zwam WH, van Walderveen MAA, van den Wijngaard IR, Dippel DWJ, Yoo AJ, Campbell B, Kunz WG, Majoie CB, Emmer BJ; CLEOPATRA; MR CLEAN Registry; CONTRAST Consortium Investigators. van Voorst H, et al. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):515-527. doi: 10.1136/jnnp-2023-331862. J Neurol Neurosurg Psychiatry. 2024. PMID: 38124162
Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial.
Olthuis SGH, Pirson FAV, Pinckaers FME, Hinsenveld WH, Nieboer D, Ceulemans A, Knapen RRMM, Robbe MMQ, Berkhemer OA, van Walderveen MAA, Lycklama À Nijeholt GJ, Uyttenboogaart M, Schonewille WJ, van der Sluijs PM, Wolff L, van Voorst H, Postma AA, Roosendaal SD, van der Hoorn A, Emmer BJ, Krietemeijer MGM, van Doormaal PJ, Roozenbeek B, Goldhoorn RB, Staals J, de Ridder IR, van der Leij C, Coutinho JM, van der Worp HB, Lo RTH, Bokkers RPH, van Dijk EI, Boogaarts HD, Wermer MJH, van Es ACGM, van Tuijl JH, Kortman HGJ, Gons RAR, Yo LSF, Vos JA, de Laat KF, van Dijk LC, van den Wijngaard IR, Hofmeijer J, Martens JM, Brouwers PJAM, Bulut T, Remmers MJM, de Jong TEAM, den Hertog HM, van Hasselt BAAM, Rozeman AD, Elgersma OEH, van der Veen B, Sudiono DR, Lingsma HF, Roos YBWEM, Majoie CBLM, van der Lugt A, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ; MR CLEAN-LATE investigators. Olthuis SGH, et al. Among authors: krietemeijer mgm. Lancet. 2023 Apr 22;401(10385):1371-1380. doi: 10.1016/S0140-6736(23)00575-5. Epub 2023 Mar 29. Lancet. 2023. PMID: 37003289 Clinical Trial.
Hemorrhage rates in patients with acute ischemic stroke treated with intravenous alteplase and thrombectomy versus thrombectomy alone.
van Kranendonk KR, Kappelhof M, Bruggeman AAE, Rinkel LA, Treurniet KM, LeCouffe N, Emmer BJ, Coutinho JM, Wolff L, van Zwam WH, van Oostenbrugge RJ, van der Lugt A, Dippel DWJ, Roos YBWEM, Marquering HA, Majoie CBLM; MR CLEAN-NO IV Investigators. van Kranendonk KR, et al. J Neurointerv Surg. 2023 Nov;15(e2):e262-e269. doi: 10.1136/jnis-2022-019569. Epub 2022 Nov 17. J Neurointerv Surg. 2023. PMID: 36396434 Clinical Trial.
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
van den Berg SA, Uniken Venema SM, Reinink H, Hofmeijer J, Schonewille WJ, Miedema I, Fransen PSS, O Pruissen DM, Raaijmakers TWM, van Dijk GW, de Leeuw FE, van Vliet JA, Kwa VIH, Kerkhoff H, van 't Net A, Boomars R, Siegers A, Lok T, Caminada K, Esteve Cuevas LM, Visser MC, Zwetsloot CP, Boomsma JMF, Schipper MH, van Eijkelenburg RPJ, Berkhemer OA, Nieboer D, Lingsma HF, Emmer BJ, van Oostenbrugge RJ, van der Lugt A, Roos YBWEM, Majoie CBLM, Dippel DWJ, Nederkoorn PJ, van der Worp HB; MR ASAP Investigators. van den Berg SA, et al. Lancet Neurol. 2022 Nov;21(11):971-981. doi: 10.1016/S1474-4422(22)00333-7. Epub 2022 Sep 1. Lancet Neurol. 2022. PMID: 36058230 Clinical Trial.
Unsupervised Deep Learning for Stroke Lesion Segmentation on Follow-up CT Based on Generative Adversarial Networks.
van Voorst H, Konduri PR, van Poppel LM, van der Steen W, van der Sluijs PM, Slot EMH, Emmer BJ, van Zwam WH, Roos YBWEM, Majoie CBLM, Zaharchuk G, Caan MWA, Marquering HA; CONTRAST Consortium Collaborators; Research leaders Consortium coordinator: Imaging assessment committee Adverse event committee Outcome assessment committee Data management group Imaging data management Biomaterials and translational group Local collaborators Research nurses Study monitors Research leaders. van Voorst H, et al. AJNR Am J Neuroradiol. 2022 Aug;43(8):1107-1114. doi: 10.3174/ajnr.A7582. Epub 2022 Jul 28. AJNR Am J Neuroradiol. 2022. PMID: 35902122 Free PMC article.
Thrombus radiomics in patients with anterior circulation acute ischemic stroke undergoing endovascular treatment.
van Voorst H, Bruggeman AAE, Yang W, Andriessen J, Welberg E, Dutra BG, Konduri PR, Arrarte Terreros N, Hoving JW, Tolhuisen ML, Kappelhof M, Brouwer J, Boodt N, van Kranendonk KR, Koopman MS, Hund HM, Krietemeijer M, van Zwam WH, van Beusekom HMM, van der Lugt A, Emmer BJ, Marquering HA, Roos YBWEM, Caan MWA, Majoie CBLM; MR CLEAN Registry investigators. van Voorst H, et al. Among authors: krietemeijer m. J Neurointerv Surg. 2023 Sep;15(e1):e79-e85. doi: 10.1136/jnis-2022-019085. Epub 2022 Jul 26. J Neurointerv Surg. 2023. PMID: 35882552
Effect of Intravenous Alteplase Treatment on First-Line Stent Retriever Versus Aspiration Alone During Endovascular Treatment.
Rinkel LA, Treurniet KM, Nieboer D, Kappelhof M, LeCouffe NE, Bruggeman AAE, van Zwam WH, Lycklama À Nijeholt GJ, Ghariq E, Uyttenboogaart M, Dippel DWJ, Roos YBWEM, Coutinho JM, Majoie CBLM, Emmer BJ; MR CLEAN-NO IV Investigators. Rinkel LA, et al. Stroke. 2022 Nov;53(11):3278-3288. doi: 10.1161/STROKEAHA.121.038390. Epub 2022 Jul 25. Stroke. 2022. PMID: 35876018 Clinical Trial.
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
van der Steen W, van de Graaf RA, Chalos V, Lingsma HF, van Doormaal PJ, Coutinho JM, Emmer BJ, de Ridder I, van Zwam W, van der Worp HB, van der Schaaf I, Gons RAR, Yo LSF, Boiten J, van den Wijngaard I, Hofmeijer J, Martens J, Schonewille W, Vos JA, Tuladhar AM, de Laat KF, van Hasselt B, Remmers M, Vos D, Rozeman A, Elgersma O, Uyttenboogaart M, Bokkers RPH, van Tuijl J, Boukrab I, van den Berg R, Beenen LFM, Roosendaal SD, Postma AA, Krietemeijer M, Lycklama G, Meijer FJA, Hammer S, van der Hoorn A, Yoo AJ, Gerrits D, Truijman MTB, Zinkstok S, Koudstaal PJ, Manschot S, Kerkhoff H, Nieboer D, Berkhemer O, Wolff L, van der Sluijs PM, van Voorst H, Tolhuisen M, Roos YBWEM, Majoie CBLM, Staals J, van Oostenbrugge RJ, Jenniskens SFM, van Dijk LC, den Hertog HM, van Es ACGM, van der Lugt A, Dippel DWJ, Roozenbeek B; MR CLEAN-MED investigators. van der Steen W, et al. Among authors: krietemeijer m. Lancet. 2022 Mar 12;399(10329):1059-1069. doi: 10.1016/S0140-6736(22)00014-9. Epub 2022 Feb 28. Lancet. 2022. PMID: 35240044 Clinical Trial.
14 results